Optimisation of treatments for oralNeisseria gonorrhoeaeinfection: Pharmacokinetics Study (STI-PK project) – study protocol for non-randomised clinical trial

Author:

Kong Fabian Y SORCID,Unemo Magnus,Lim Shueh H,Latch Ngaire,Williamson Deborah A,Roberts Jason A,Wallis Steven C,Parker Suzanne L,Landersdorfer Cornelia B,Yap Tami,Fairley Christopher K,Chow Eric P F,Lewis David A,Hammoud Mohamed A,Hocking Jane S

Abstract

IntroductionNeisseria gonorrhoeaeinfections are common and incidence increasing. Oropharyngeal infections are associated with greater treatment failure compared with other sites and drive transmission to anogenital sites through saliva. Gonococcal resistance is increasing and new treatments are scarce, therefore, clinicians must optimise currently available and emerging treatments in order to have efficacious therapeutic options. This requires pharmacokinetic data from the oral cavity/oropharynx, however, availability of such information is currently limited.Methods and analysisHealthy male volunteers (participants) recruited into the study will receive single doses of either ceftriaxone 1 g, cefixime 400 mg or ceftriaxone 500 mg plus 2 g azithromycin. Participants will provide samples at 6-8 time points (treatment regimen dependent) from four oral sites, two oral fluids, one anorectal swab and blood. Participants will complete online questionnaires about their medical history, sexual practices and any side effects experienced up to days 5–7. Saliva/oral mucosal pH and oral microbiome analysis will be undertaken. Bioanalysis will be conducted by liquid chromatography-mass spectrometry. Drug concentrations over time will be used to develop mathematical models for optimisation of drug dosing regimens and to estimate pharmacodynamic targets of efficacy.Ethics and disseminationThis study was approved by Royal Melbourne Hospital Human Research Ethics Committee (60370/MH-2021). The study results will be submitted for publication in peer-reviewed journals and reported at conferences. Summary results will be sent to participants requesting them. All data relevant to the study will be included in the article or uploaded as supplementary information.Trial registration numberACTRN12621000339853.

Funder

Australian National Health and Medical Research Council

Publisher

BMJ

Subject

General Medicine

Reference40 articles.

1. World Health Organisation . actions for impact. In: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. accountability for the global health sector strategies 2016–2021, 2021.

2. National Notifiable Diseases Surveillance System . Number of notifications of gonococcal infections, Australia, by age group and sex, 2021.

3. Centers for Disease Control and Prevention . Sexually Transmitted Disease Surveillance 2017 report. In: Atlanta: U.S : Department of Health and Human Services, 2017.

4. Public Health England (PHE) . Sexually transmitted infections and screening for Chlamydia in England, 2018. 13, 2019.

5. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature;Chan;Infect Dis Obstet Gynecol,2016

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3